Published in Curr Psychiatry Rev on May 01, 2014
Association Between Initial Opioid Prescribing Patterns and Subsequent Long-Term Use Among Opioid-Naïve Patients: A Statewide Retrospective Cohort Study. J Gen Intern Med (2016) 0.90
Analysis of morphine responses in mice reveals a QTL on Chromosome 7. F1000Res (2016) 0.84
Who Benefits from Chronic Opioid Therapy? Rethinking the Question of Opioid Misuse Risk. Healthcare (Basel) (2016) 0.75
Adding Genetic Testing to Evidence-Based Guidelines to Determine the Safest and Most Effective Chronic Pain Treatment for Injured Workers. Int J Biomed Sci (2015) 0.75
Replication of ZNF804A gene variant associations with risk of heroin addiction. Genes Brain Behav (2015) 0.75
Addiction and dependence in DSM-V. Addiction (2010) 13.28
The neural basis of addiction: a pathology of motivation and choice. Am J Psychiatry (2005) 12.53
Developmental neurocircuitry of motivation in adolescence: a critical period of addiction vulnerability. Am J Psychiatry (2003) 7.11
Impulsivity resulting from frontostriatal dysfunction in drug abuse: implications for the control of behavior by reward-related stimuli. Psychopharmacology (Berl) (1999) 7.06
Major increases in opioid analgesic abuse in the United States: concerns and strategies. Drug Alcohol Depend (2005) 6.91
Nucleus accumbens D2/3 receptors predict trait impulsivity and cocaine reinforcement. Science (2007) 6.75
The glutamate homeostasis hypothesis of addiction. Nat Rev Neurosci (2009) 5.97
Risk factors for adolescent substance abuse and dependence: data from a national sample. J Consult Clin Psychol (2000) 5.66
Opioids excite dopamine neurons by hyperpolarization of local interneurons. J Neurosci (1992) 5.27
Review. Neural mechanisms underlying the vulnerability to develop compulsive drug-seeking habits and addiction. Philos Trans R Soc Lond B Biol Sci (2008) 4.85
Co-occurrence of abuse of different drugs in men: the role of drug-specific and shared vulnerabilities. Arch Gen Psychiatry (1998) 4.69
Single-nucleotide polymorphism in the human mu opioid receptor gene alters beta-endorphin binding and activity: possible implications for opiate addiction. Proc Natl Acad Sci U S A (1998) 4.67
Familial transmission of substance use disorders. Arch Gen Psychiatry (1998) 4.57
Stress, dysregulation of drug reward pathways, and the transition to drug dependence. Am J Psychiatry (2007) 4.37
Dorsal anterior cingulate cortex: a role in reward-based decision making. Proc Natl Acad Sci U S A (2001) 4.20
Variant brain-derived neurotrophic factor (BDNF) (Met66) alters the intracellular trafficking and activity-dependent secretion of wild-type BDNF in neurosecretory cells and cortical neurons. J Neurosci (2004) 3.47
Illicit psychoactive substance use, heavy use, abuse, and dependence in a US population-based sample of male twins. Arch Gen Psychiatry (2000) 3.33
Dopamine D4 receptor (D4DR) exon III polymorphism associated with the human personality trait of Novelty Seeking. Nat Genet (1996) 2.92
Identification and characterization of ANKK1: a novel kinase gene closely linked to DRD2 on chromosome band 11q23.1. Hum Mutat (2004) 2.89
Hippocampus-specific deletion of BDNF in adult mice impairs spatial memory and extinction of aversive memories. Mol Psychiatry (2007) 2.84
Predicting aberrant behaviors in opioid-treated patients: preliminary validation of the Opioid Risk Tool. Pain Med (2005) 2.73
Autoradiographic differentiation of mu, delta, and kappa opioid receptors in the rat forebrain and midbrain. J Neurosci (1987) 2.53
Polysubstance abuse-vulnerability genes: genome scans for association, using 1,004 subjects and 1,494 single-nucleotide polymorphisms. Am J Hum Genet (2001) 2.26
The neurobiology and genetics of impulse control disorders: relationships to drug addictions. Biochem Pharmacol (2007) 2.22
The Harvard Twin Study of Substance Abuse: what we have learned. Harv Rev Psychiatry (2001) 2.20
Changes in illicit opioid use across Canada. CMAJ (2006) 2.20
Illicit opioid use and its key characteristics: a select overview and evidence from a Canadian multisite cohort of illicit opioid users (OPICAN). Can J Psychiatry (2006) 2.16
Molecular neurobiology of drug addiction. Annu Rev Med (2004) 2.16
Opioid pharmacology. Pain Physician (2008) 2.12
BDNF controls dopamine D3 receptor expression and triggers behavioural sensitization. Nature (2001) 1.84
The single nucleotide polymorphism A118G alters functional properties of the human mu opioid receptor. J Neurochem (2007) 1.78
The neurobiology of addictive disorders. Clin Neuropharmacol (2009) 1.76
Illicit opioid use in Canada: comparing social, health, and drug use characteristics of untreated users in five cities (OPICAN study). J Urban Health (2005) 1.73
A single nucleotide polymorphic mutation in the human mu-opioid receptor severely impairs receptor signaling. J Biol Chem (2000) 1.65
Role of the brain-derived neurotrophic factor at glutamatergic synapses. Br J Pharmacol (2007) 1.64
Women who abuse prescription opioids: findings from the Addiction Severity Index-Multimedia Version Connect prescription opioid database. Drug Alcohol Depend (2009) 1.63
An adoption study of genetic and environmental factors in drug abuse. Arch Gen Psychiatry (1986) 1.62
Substantial attributable risk related to a functional mu-opioid receptor gene polymorphism in association with heroin addiction in central Sweden. Mol Psychiatry (2004) 1.56
Brain DA D2 receptors predict reinforcing effects of stimulants in humans: replication study. Synapse (2002) 1.56
Genomewide suggestive linkage of opioid dependence to chromosome 14q. Hum Mol Genet (2007) 1.54
Mu opioid receptor: a gateway to drug addiction. Curr Opin Neurobiol (2004) 1.53
Genetic and environmental influences on posttraumatic stress disorder, alcohol and drug dependence in twin pairs. Drug Alcohol Depend (2000) 1.51
Direct costs of opioid abuse in an insured population in the United States. J Manag Care Pharm (2005) 1.45
Pain management in post-craniotomy patients: a survey of canadian neurosurgeons. Can J Neurol Sci (2011) 1.43
Association of the kappa-opioid system with alcohol dependence. Mol Psychiatry (2006) 1.42
Non-medical use of prescription opioids and public health in Canada: an urgent call for research and interventions development. Can J Public Health (2008) 1.41
The OPRD1 and OPRK1 loci in alcohol or drug dependence: OPRD1 variation modulates substance dependence risk. Mol Psychiatry (2007) 1.41
Treating opioid dependence. Growing implications for primary care. Arch Intern Med (2004) 1.39
Genetic and environmental influences on transitions in drug use. Behav Genet (1999) 1.29
Brain-derived neurotrophic factor (Val66Met) genetic polymorphism is associated with substance abuse in males. Brain Res Mol Brain Res (2005) 1.21
Search for genetic markers and functional variants involved in the development of opiate and cocaine addiction and treatment. Ann N Y Acad Sci (2010) 1.16
Redefinition of the human kappa opioid receptor gene (OPRK1) structure and association of haplotypes with opiate addiction. Pharmacogenetics (2004) 1.16
Regulations of opioid dependence by opioid receptor types. Pharmacol Ther (2001) 1.10
The D(2) dopamine receptor A(1) allele and opioid dependence: association with heroin use and response to methadone treatment. Am J Med Genet (2000) 1.10
Geographical variation in opioid prescribing and opioid-related mortality in Ontario. Healthc Q (2011) 1.06
Prevention of prescription opioid abuse: the role of the dentist. J Am Dent Assoc (2011) 1.05
Excess dopamine D4 receptor (D4DR) exon III seven repeat allele in opioid-dependent subjects. Mol Psychiatry (1997) 1.04
A118g polymorphism in mu opioid receptor gene (oprm1): association with opiate addiction in subjects of Indian origin. J Integr Neurosci (2007) 1.03
Human kappa opioid receptor gene (OPRK1) polymorphism is associated with opiate addiction. Am J Med Genet B Neuropsychiatr Genet (2007) 1.02
Control of hormonal stress reactivity by the endogenous opioid system. Psychoneuroendocrinology (2008) 1.02
Association between a delta opioid receptor gene polymorphism and heroin dependence in man. Neuroreport (1997) 0.98
Pain mechanisms in patients with chronic pain. Clin Drug Investig (2012) 0.95
Potential association of DRD2 and DAT1 genetic variation with heroin dependence. Neurosci Lett (2009) 0.93
Human delta-opioid receptor gene and susceptibility to heroin and alcohol dependence. Am J Med Genet (1999) 0.92
Empirical view of opioid dependence. J Manag Care Pharm (2010) 0.91
Homozygosity at the dopamine D3 receptor gene is associated with opiate dependence. Mol Psychiatry (1998) 0.91
Association between brain-derived neurotrophic factor 196 G/A polymorphism and personality traits in healthy subjects. Am J Med Genet B Neuropsychiatr Genet (2004) 0.90
Association analysis of the dopamine D4 gene exon III VNTR and heroin abuse in Chinese subjects. Mol Psychiatry (1997) 0.90
Associations among types of impulsivity, substance use problems and neurexin-3 polymorphisms. Drug Alcohol Depend (2011) 0.87
Differential effects of the dopamine D2/D3 receptor antagonist sulpiride on self-administration of morphine into the ventral tegmental area or the nucleus accumbens. Psychopharmacology (Berl) (2002) 0.87
Brain-derived neurotrophic factor controls cannabinoid CB1 receptor function in the striatum. J Neurosci (2010) 0.87
Effects of the DRD4 genotype on neural networks associated with executive functions in children and adolescents. Dev Cogn Neurosci (2012) 0.85
Risk factors for adolescent substance abuse. J Learn Disabil (2004) 0.84
Musculoskeletal pain: prescription of NSAID and weak opioid by primary health care physicians in Sweden 2004-2008 - a retrospective patient record review. J Pain Res (2010) 0.83
The role of endogenous opioids in the placebo effect in post-traumatic stress disorder. Forsch Komplementarmed Klass Naturheilkd (2004) 0.82
Polymorphisms of brain-derived neurotrophic factor associated with heroin dependence. Neurosci Lett (2011) 0.82
BDNF variability in opioid addicts and response to methadone treatment: preliminary findings. Genes Brain Behav (2008) 0.82
Nerve growth factor β polypeptide (NGFB) genetic variability: association with the methadone dose required for effective maintenance treatment. Pharmacogenomics J (2011) 0.82
Association of VNTR polymorphisms in the MAOA promoter and DRD4 exon 3 with heroin dependence in male Chinese addicts. World J Biol Psychiatry (2010) 0.79
Variation in NGFB is associated with primary affective disorders in women. Am J Med Genet B Neuropsychiatr Genet (2011) 0.78
The role of glutamate in physical dependence on opioids. Jpn J Pharmacol (1998) 0.77
A two-year study of patterns and predictors of substance use among Mexican American youth. Adolescence (1998) 0.77
Growing-up with a substance-dependent parent: development of subjective risk and protective factors. Subst Use Misuse (2010) 0.76
Dopamine receptors, motor responses, and dopaminergic agonists. Neurologist (2011) 0.76
Review of regulatory programs and new opioid technologies in chronic pain management: balancing the risk of medication abuse with medical need. J Manag Care Pharm (2010) 0.76